ICUI - ICU Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
223.58
-4.04 (-1.77%)
As of 3:15PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close 227.62
Open 225.64
Bid 222.45 x 900
Ask 223.12 x 1000
Day's Range 222.45 - 226.00
52 Week Range 210.94 - 321.70
Volume 75,285
Avg. Volume 209,093
Market Cap 4.609B
Beta (3Y Monthly) 0.59
PE Ratio (TTM) 88.23
EPS (TTM) N/A
Earnings Date N/A
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A
Trade prices are not sourced from all markets
  • Markit 2 days ago

    See what the IHS Markit Score report has to say about ICU Medical Inc.

    ICU Medical Inc NASDAQ/NGS:ICUIView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for ICUI with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $2.27 billion over the last one-month into ETFs that hold ICUI are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Thomson Reuters StreetEvents 3 days ago

    Edited Transcript of ICUI earnings conference call or presentation 9-May-19 8:30pm GMT

    Q1 2019 ICU Medical Inc Earnings Call

  • ICU Medical, Inc. (ICUI) Q1 2019 Earnings Call Transcript
    Motley Fool 14 days ago

    ICU Medical, Inc. (ICUI) Q1 2019 Earnings Call Transcript

    ICUI earnings call for the period ending March 31, 2019.

  • ICU Medical (ICUI) Q1 Earnings and Revenues Beat Estimates
    Zacks 14 days ago

    ICU Medical (ICUI) Q1 Earnings and Revenues Beat Estimates

    ICU Medical (ICUI) delivered earnings and revenue surprises of 18.35% and 4.13%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press 14 days ago

    ICU Medical: 1Q Earnings Snapshot

    On a per-share basis, the San Clemente, California-based company said it had profit of $1.44. Earnings, adjusted for one-time gains and costs, were $2.58 per share. The medical device maker posted revenue ...

  • Is ICU Medical, Inc. (NASDAQ:ICUI) Excessively Paying Its CEO?
    Simply Wall St. 15 days ago

    Is ICU Medical, Inc. (NASDAQ:ICUI) Excessively Paying Its CEO?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Vivek Jain has been the CEO of ICU Medical, Inc. (NASDAQ:ICUI) since 2014. This analysis a...

  • Earnings Preview: ICU Medical (ICUI) Q1 Earnings Expected to Decline
    Zacks 21 days ago

    Earnings Preview: ICU Medical (ICUI) Q1 Earnings Expected to Decline

    ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • CONMED (CNMD) Beats on Q1 Earnings, Raises '19 Guidance
    Zacks 28 days ago

    CONMED (CNMD) Beats on Q1 Earnings, Raises '19 Guidance

    Higher revenues, solid segmental performance and strong adjusted gross margins benefit CONMED's (CNMD) Q1 earnings. However, high long-term debt remains a concern.

  • Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates
    Zacks 28 days ago

    Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates

    Higher revenues, growth in APAC and strong operating margin benefit Baxter's (BAX) Q1 earnings. However, weak performance at Medication Delivery and Clinical Nutrition remains a concern.

  • Edwards Lifesciences (EW) Q1 Earnings Beat, EPS View Raised
    Zacks 28 days ago

    Edwards Lifesciences (EW) Q1 Earnings Beat, EPS View Raised

    Edwards Lifesciences (EW) gains on strong segmental contributions in Q1.

  • Boston Scientific (BSX) Misses Q1 Earnings, Tightens EPS View
    Zacks 29 days ago

    Boston Scientific (BSX) Misses Q1 Earnings, Tightens EPS View

    Boston Scientific (BSX) is investing in new technologies and the global markets, which in turn, aids the uptick in sales across its most geographies in Q1.

  • Thermo Fisher (TMO) Beats on Q1 Earnings, Raises '19 View
    Zacks 29 days ago

    Thermo Fisher (TMO) Beats on Q1 Earnings, Raises '19 View

    Thermo Fisher (TMO) reports strong Laboratory Products and Services performance, flaunting robust global demand.

  • Accuray (ARAY) Q3 Earnings Top Estimates, Gross Orders Rise
    Zacks 29 days ago

    Accuray (ARAY) Q3 Earnings Top Estimates, Gross Orders Rise

    Solid demand for Accuray's (ARAY) Radixact, CyberKnife and TomoTherapy platforms continue to boost business.

  • Merit Medical (MMSI) Q1 Earnings & Revenues Beat Estimates
    Zacks 29 days ago

    Merit Medical (MMSI) Q1 Earnings & Revenues Beat Estimates

    Higher revenues, solid segmental performance and strong adjusted gross margins benefit Merit Medical's (MMSI) Q1 earnings. However, higher expenses remain a concern.

  • Stryker (SYK) Q1 Earnings Beat Estimates, Revenues In Line
    Zacks 29 days ago

    Stryker (SYK) Q1 Earnings Beat Estimates, Revenues In Line

    Higher revenues, solid segmental performance and strong organic growth across businesses benefit Stryker's (SYK) Q1 earnings.

  • Quest Diagnostics (DGX) Q1 Earnings Top Mark, Margins Down
    Zacks last month

    Quest Diagnostics (DGX) Q1 Earnings Top Mark, Margins Down

    Quest Diagnostics (DGX) currently concentrates on its core diagnostic information services business and tries to maintain discipline in capital deployment.

  • Were Hedge Funds Right About Souring On ICU Medical, Inc. (ICUI)?
    Insider Monkey last month

    Were Hedge Funds Right About Souring On ICU Medical, Inc. (ICUI)?

    Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth also depends on it. Regardless of the various methods used by elite investors like David Tepper and David […]

  • Need To Know: ICU Medical, Inc. (NASDAQ:ICUI) Insiders Have Been Selling Shares
    Simply Wall St. last month

    Need To Know: ICU Medical, Inc. (NASDAQ:ICUI) Insiders Have Been Selling Shares

    We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So before you...

  • Baxter (BAX) Soars to 52-Week High, Time to Cash Out?
    Zacks 2 months ago

    Baxter (BAX) Soars to 52-Week High, Time to Cash Out?

    Baxter (BAX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • Reuters 2 months ago

    Smiths plans to list medical unit, focus on industrial technology

    The healthcare business has suffered from product delays, stricter European regulations and two lost contracts in the United States. A plan to merge it with U.S.-based ICU Medical fell through in September because Smiths and ICU could not agree on terms. "Pursuing a demerger of Smiths Medical will lead to two stronger companies, each...maximising the opportunities in their respective markets," Chief Executive Andy Reynolds Smith said.

  • Looking for a Growth Stock? 3 Reasons Why ICU Medical (ICUI) is a Solid Choice
    Zacks 2 months ago

    Looking for a Growth Stock? 3 Reasons Why ICU Medical (ICUI) is a Solid Choice

    ICU Medical (ICUI) is well positioned to outperform the market, as it exhibits above-average growth in financials.